GSK Plc Financials
| GLAXF Stock | USD 16.87 0.17 1.00% |
GSK |
Understanding current and past GSK Plc Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GSK Plc's financial statements are interrelated, with each one affecting the others. For example, an increase in GSK Plc's assets may result in an increase in income on the income statement.
GSK Plc Stock Summary
GSK Plc competes with Santen Pharmaceutical, Ono Pharmaceutical, Grifols SA, Pfizer, and Sanofi ADR. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | GB0009252882 |
| Business Address | 980 Great West |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | Dow Jones Industrial |
| Website | www.gsk.com |
| Phone | 44 20 8047 5000 |
| Currency | USD - US Dollar |
GSK Plc Key Financial Ratios
There are many critical financial ratios that GSK Plc's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that GSK plc reports annually and quarterly.GSK Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GSK Plc's current stock value. Our valuation model uses many indicators to compare GSK Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GSK Plc competition to find correlations between indicators driving GSK Plc's intrinsic value. More Info.GSK plc is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers reporting about 0.21 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for GSK plc is roughly 4.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GSK Plc's earnings, one of the primary drivers of an investment's value.GSK plc Systematic Risk
GSK Plc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GSK Plc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on GSK plc correlated with the market. If Beta is less than 0 GSK Plc generally moves in the opposite direction as compared to the market. If GSK Plc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GSK plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GSK Plc is generally in the same direction as the market. If Beta > 1 GSK Plc moves generally in the same direction as, but more than the movement of the benchmark.
GSK Plc December 14, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GSK Plc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GSK plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of GSK plc based on widely used predictive technical indicators. In general, we focus on analyzing GSK Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GSK Plc's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 15.33 | |||
| Value At Risk | (5.46) | |||
| Potential Upside | 4.48 |
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |